T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.

Autor: Datwani, Sneha¹ (AUTHOR) sneha_datwani@sfu.ca, Kalikawe, Rebecca¹ (AUTHOR) rebecca_kalikawe@sfu.ca, Waterworth, Rachel¹ (AUTHOR) rachel_waterworth@sfu.ca, Mwimanzi, Francis M.¹ (AUTHOR) francis_method_mwimanzi@sfu.ca, Liang, Richard² (AUTHOR) rliang@bccfe.ca, Sang, Yurou¹ (AUTHOR) yurou_sang@sfu.ca, Lapointe, Hope R.² (AUTHOR) hrlapointe@bccfe.ca, Cheung, Peter K.^1,2 (AUTHOR) nmorangarcia@bccfe.ca, Omondi, Fredrick Harrison^1,2 (AUTHOR) fredrick_omondi@sfu.ca, Duncan, Maggie C.^1,2 (AUTHOR) maggie_duncan@sfu.ca, Barad, Evan^1,2 (AUTHOR) drjm@bccfe.ca, Speckmaier, Sarah² (AUTHOR), Moran-Garcia, Nadia² (AUTHOR), DeMarco, Mari L.^3,4 (AUTHOR) mromney@providencehealth.bc.ca, Hedgcock, Malcolm⁵ (AUTHOR) malcolmh@spectrum-health.net, Costiniuk, Cecilia T.^6,7 (AUTHOR) cecilia.costiniuk@mcgill.ca, Hull, Mark^2,8 (AUTHOR), Harris, Marianne^2,9 (AUTHOR), Romney, Marc G.^3,4 (AUTHOR), Montaner, Julio S. G.^2,8 (AUTHOR)

Publikováno v: Viruses (1999-4915). May2024, Vol. 16 Issue 5, p661. 15p.

Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults

Autor: Sneha Datwani, Rebecca Kalikawe, Francis Mwimanzi, Sarah Speckmaier, Richard Liang, Yurou Sang, Rachel Waterworth, Fatima Yaseen, Hope Lapointe, Evan Barad, Mari DeMarco, Daniel Holmes, Janet Simons, Julio Montaner, Marc Romney, Zabrina Brumme, Mark Brockman

Publikováno v: Pathogens and Immunity, Vol 8, Iss 1 (2023)

Introduction: While older adults generally mount weaker antibody responses to a primary COVID-19 vaccine series, T-cell responses remain less well characterized in this population. We compared SARS-CoV-2 spike-specific T-cell responses after 2- and 3

Externí odkaz: https://doaj.org/article/7734f4a1d97144cb85ec4a971bac0d3e

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination

Autor: Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, Sneha Datwani, Rachel Waterworth, Gisele Umviligihozo, Siobhan Ennis, Landon Young, Winnie Dong, Don Kirkby, Laura Burns, Victor Leung, Daniel T. Holmes, Mari L. DeMarco, Janet Simons, Nancy Matic, Julio S.G. Montaner, Chanson J. Brumme, Natalie Prystajecky, Masahiro Niikura, Christopher F. Lowe, Marc G. Romney, Mark A. Brockman, Zabrina L. Brumme

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

SARS-CoV-2 Omicron infections are common among individuals who are vaccinated or have recovered from prior variant infection, but few reports have immunologically assessed serial Omicron infections. We characterized SARS-CoV-2 humoral responses in an

Externí odkaz: https://doaj.org/article/2a230b967aaf4881b88dbe6f3a4df5ec

Novel Acoustic Loading of a Mass Spectrometer: Toward Next-Generation High-Throughput MS Screening

Autor: Sinclair, Ian ^*, Stearns, Rick, Pringle, Steven, Wingfield, Jonathan, Datwani, Sammy, Hall, Eric, Ghislain, Luke, Majlof, Lars, Bachman, Martin

Publikováno v: In SLAS Technology February 2016 21(1):19-26

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

Autor: Hope R Lapointe, Francis Mwimanzi, Peter K Cheung, Yurou Sang, Fatima Yaseen, Gisele Umviligihozo, Rebecca Kalikawe, Sarah Speckmaier, Nadia Moran-Garcia, Sneha Datwani, Maggie C Duncan, Olga Agafitei, Siobhan Ennis, Landon Young, Hesham Ali, Bruce Ganase, F Harrison Omondi, Winnie Dong, Junine Toy, Paul Sereda, Laura Burns, Cecilia T Costiniuk, Curtis Cooper, Aslam H Anis, Victor Leung, Daniel T Holmes, Mari L DeMarco, Janet Simons, Malcolm Hedgcock, Natalie Prystajecky, Christopher F Lowe, Ralph Pantophlet, Marc G Romney, Rolando Barrios, Silvia Guillemi, Chanson J Brumme, Julio S G Montaner, Mark Hull, Marianne Harris, Masahiro Niikura, Mark A Brockman, Zabrina L Brumme

Publikováno v: The Journal of Infectious Diseases. 227:838-849

Background Longer-term humoral responses to 2-dose coronavirus disease 2019 (COVID-19) vaccines remain incompletely characterized in people living with human immunodeficiency virus (HIV) (PLWH), as do initial responses to a third dose. Methods We mea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::306eb323d6a947cf8c560a7af93c6dec
https://doi.org/10.1093/infdis/jiac229